文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

关于“细胞疗法、双特异性抗体及其他抗癌免疫疗法”的社论

Editorial on "Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer".

作者信息

Golubovskaya Vita

机构信息

Promab Biotechnologies, 2600 Hilltop Drive, Richmond, CA 94806, USA.

出版信息

Cancers (Basel). 2023 Oct 19;15(20):5053. doi: 10.3390/cancers15205053.

DOI:10.3390/cancers15205053
PMID:37894420
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10605091/
Abstract

This Special Issue in , "Cell Therapy, Bispecific Antibodies and other Immunotherapies Against Cancer", includes interesting reports and reviews on cell therapies and bispecific antibodies [...].

摘要

本期特刊《细胞疗法、双特异性抗体及其他抗癌免疫疗法》包含了关于细胞疗法和双特异性抗体的有趣报告与综述[...]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c58/10605091/9b37fad43693/cancers-15-05053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c58/10605091/9b37fad43693/cancers-15-05053-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c58/10605091/9b37fad43693/cancers-15-05053-g001.jpg

相似文献

[1]
Editorial on "Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer".

Cancers (Basel). 2023-10-19

[2]
TCR β chain-directed bispecific antibodies for the treatment of T cell cancers.

Sci Transl Med. 2021-3-10

[3]
Immunotherapies Old and New: Hematopoietic Stem Cell Transplant, Chimeric Antigen Receptor T Cells, and Bispecific Antibodies for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Curr Hematol Malig Rep. 2021-2

[4]
Clinical Development and Therapeutic Applications of Bispecific Antibodies for Hematologic Malignancies.

Cancer Treat Res. 2022

[5]
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy.

Clin Cancer Res. 2021-10-15

[6]
Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer.

Expert Opin Biol Ther. 2022-8

[7]
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast.

Adv Ther. 2023-8

[8]
Bispecific antibodies in cancer immunotherapy.

Ther Adv Vaccines Immunother. 2018-2

[9]
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies.

J Immunother Cancer. 2022-11

[10]
Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.

Arch Pharm Res. 2023-3

引用本文的文献

[1]
Advances and challenges in anti-cancer vaccines for multiple myeloma.

Front Immunol. 2024

本文引用的文献

[1]
Recent Advances in Antitumor Dendritic Cell Vaccines.

Cancer Biother Radiopharm. 2023-9

[2]
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.

Int J Mol Sci. 2023-8-29

[3]
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations.

Cells. 2023-8-25

[4]
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC).

Cancers (Basel). 2023-6-13

[5]
T-Cell Engagers in Solid Cancers-Current Landscape and Future Directions.

Cancers (Basel). 2023-5-18

[6]
Dendritic cell vaccine trials in gliomas: Untangling the lines.

Neuro Oncol. 2023-10-3

[7]
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy.

Front Immunol. 2023

[8]
Dendritic cell-based immunotherapy: a potential player in oral cancer therapeutics.

Immunotherapy. 2023-4

[9]
Advances in NK cell therapy for hematologic malignancies: NK source, persistence and tumor targeting.

Blood Rev. 2023-7

[10]
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.

Cancers (Basel). 2023-1-20

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索